EYE ‐ CODE Protocol for the Nonophthalmologist for Treatment of Retinal Artery Occlusion After Intra‐Arterial Injection of Soft‐Tissue Fillers: 2025 Update
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70336 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Sheila Barbarino und 2 weiteren Autor:innen. Beteiligte Einrichtung: Barbarino Surgical Arts, Austin, Texas, USA. Hauptthemen laut MEDLINE: Retinal Artery Occlusion, Dermal Fillers, Cosmetic Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vision loss following a facial esthetic procedure with soft‐tissue fillers is an event for which there is only a short treatment window to restore blood flow before irreversible ischemic damage occurs.
Objective
To provide a current standardized treatment approach for the management of retinal artery occlusion after intra‐arterial injection of soft‐tissue fillers.
Methods
This document provides an updated, simple, and evidence‐based protocol for acute treatment in the office setting using the acronym EYE‐CODE: EYE (I call retinal referral center), C (check vision and optic nerve function), O (ocular massage), D (decrease intraocular pressure), and E (erase filler).
Results
The EYE‐CODE protocol assists esthetic physicians to determine the extent of vision loss and provides an initial treatment strategy using medications likely to be available in most practices. This includes agents that reduce intraocular pressure, improve retinal perfusion, and potentially dissolve the filler embolus and any associated blood clots. Suggestions are also made for treatments that can be continued by an emergency ophthalmologist.
Conclusion
The EYE‐CODE 2025 update provides physicians with a comprehensive reference for the management of retinal artery occlusion caused by soft‐tissue filler injections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barbarino Surgical Arts, Austin, Texas, USA.
- SOM Aesthetics, Encinitas, California, USA.
- Center for Sight, Sarasota, Florida, USA.
ORCID-Profile: Sheila Barbarino, Saami Khalifian
Zitieren
APA
Barbarino, S., Khalifian, S., & Fezza, J. (2025). EYE ‐ CODE Protocol for the Nonophthalmologist for Treatment of Retinal Artery Occlusion After Intra‐Arterial Injection of Soft‐Tissue Fillers: 2025 Update. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70336
Vancouver
Barbarino S, Khalifian S, Fezza J. EYE ‐ CODE Protocol for the Nonophthalmologist for Treatment of Retinal Artery Occlusion After Intra‐Arterial Injection of Soft‐Tissue Fillers: 2025 Update. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70336
BibTeX
@article{Barbarino2025,
author = {Barbarino, Sheila and Khalifian, Saami and Fezza, John},
title = {EYE ‐ CODE Protocol for the Nonophthalmologist for Treatment of Retinal Artery Occlusion After Intra‐Arterial Injection of Soft‐Tissue Fillers: 2025 Update},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70336}
}
EUVIMED